Latest filing published 04 Mar 2025 for AtriCure, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Deborah Lee Yount: trading record in brief
This profile gathers the share dealings of Deborah Lee Yount in AtriCure, Inc., where the filings describe the role as senior executive. We count 12 filings; the first trade dates from 1 June 2022 and the latest from 1 March 2025.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 4 March 2025: a share grant of €446k, in AtriCure, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Deborah Lee Yount
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,853 shares0Common StockSEC:0001323885-25-000020:0
- 2,589 shares@ US$45.7872.9% of flowCommon StockSEC:0001323885-24-000112:0
- 707 shares@ US$19.358.5% of flowCommon StockSEC:0001323885-24-000096:0
- 19,294 shares0Common StockSEC:0001323885-24-000038:0
- 98 shares@ US$30.341.8% of flowCommon StockSEC:0001323885-24-000002:0
- 450 shares@ US$38.1110.5% of flowCommon StockSEC:0001323885-23-000089:0
- 12,239 shares0Common StockSEC:0001323885-23-000029:0
- 294 shares@ US$34.866.4% of flowCommon StockSEC:0001323885-23-000002:0
- 16,900 shares0Common StockSEC:0001323885-22-000085:0
9 of 9 declarations
